Promoter holding
64.27%
GI
Genesis Ibrc India Limited - Due diligence report
A 360° intelligence report on Genesis Ibrc India Limited: trust score, financial health, credit view, compliance, directors, growth and dist…
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Genesis Ibrc India Limited — 360° Intelligence Report
Generated from MCA filings & public records77/100
Trust Score
Low Risk
Genesis Ibrc India Limited is assessed as Low Risk with a Trust Score of 77/100. Genesis Ibrc India Limited is an active public limited indian non-government company incorporated in 1992, operating in the Chemicals sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.
Report generated on 17 Jul 2026 from the latest processed filings. Genesis Ibrc India Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
46/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
70/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- No open charges - unencumbered balance sheet.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 0 open (-) · 8 satisfied (6.38 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Industrial Development Bank Of India | 1 | 48.0 cr |
| Canara Bank | 7 | 48.0 cr |
Compliance Score: 46/100 Caution Indicated
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Flagged by authority: BSE.
- Litigation present in 2 court forum(s).
- 1 auditor resignation(s) filed - latest: Sanjeeva Rao & Associates on 2014-11-15.
- 1 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| DURGA VENKATA VARA CHADALAWADA PRASAD RAO | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PRASADA RAO KALLURI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MOHAMMED BABA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| DURGA VENKATA VARA CHADALAWADA PRASAD RAO | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| BALAKRISHNA KOPPULA | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VANITHA NAGULAVARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| RAMAKRISHNA SUBRAY HEGDE | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 7 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2025)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2025 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
4 allotment(s) · 7 transfer(s)
Promoters hold a minority stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Genesis I.b.r.c. Private Limited | Subsidiary Company | 74.00% |
Key managerial personnel: DURGA VENKATA VARA CHADALAWADA PRASAD RAO (CFO) · DURGA VENKATA VARA CHADALAWADA PRASAD RAO (CFO) · BALAKRISHNA KOPPULA (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 70 · Distress 80
Growth signals & trust indicators
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 33+ years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 61% in a year.
Compliance score is weak (46/100).
1 auditor resignation(s) on record - review the stated reasons.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence66/100
Review suggested
Suitability as a supplier / customer counterparty.
- Check the compliance flags before onboarding.
- 1 distress signal(s) - see Risk Center.
- Financial filings available for verification.
Banker assessment81/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- No existing security registered - first-charge position available.
- Compliance gaps should be priced into terms.
Investor view79/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events31 Mar 2025
Latest balance sheet
Filed with ROC
30 Sep 2024
Last AGM held
Annual general meeting
04 Apr 2024
Director appointed
RAMAKRISHNA SUBRAY HEGDE (Company Secretary)
31 Oct 2022
Director ceased
SRIDHAR PENTELA
08 Apr 2022
Director ceased
Ashok Amara
30 Jun 2021
Director ceased
KARAMSETTY RATNAKARA RAO
29 Jun 2021
Director appointed
BALAKRISHNA KOPPULA (Whole-time director)
Director ceased
BALAKRISHNA KOPPULA
28 Sep 2020
Director ceased
PRASADA RAO KALLURI
Director ceased
MOHAMMED BABA
02 Jan 2020
Director ceased
VENKATA YERRA KRISHNA RAO
Director ceased
MAJETI VENKATASESHA KUMAR SRIDHAR
01 Jan 2020
Director appointed
PRASADA RAO KALLURI (Director)
Director appointed
MOHAMMED BABA (Director)
27 Sep 2019
Director ceased
VANITHA NAGULAVARI
10
Key Observations
Auto-generated from the data aboveDebt-to-equity stands at 38% - manageable leverage.
Net worth is positive.
7 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
All 8 registered charge(s) stand satisfied - past borrowings repaid.
Promoters hold a minority stake as per the FY 2025 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 4 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Emmessar Biotech & Nutrition | L24110MH1992PLC065942 | Raigad, Maharashtra, India |
| Ayurvedganga | L99999MH1989PLC053392 | Palghar, Maharashtra, India |
| Zeon Lifesciences | U15209HP1987PLC007355 | Himachal Pradesh, Himachal Pradesh, India |
| Medisys Biotech Private Limited | U24231HP2005PTC030915 | Kala Amb, Himachal Pradesh, India |
| Rishab Healthcare Private Limited | U51397CH2005PTC027979 | Chandigarh, Chandigarh, India |
| Rathi Graphic Technologies Limited | L26960UP1991PLC013770 | Ghaziabad, Uttar Pradesh, India |
| Stelis Biopharma | L74140MH2007PLC432497 | Thane, Maharashtra, India |
| Norris Medicines | L24230GJ1990PLC086581 | Ankleshwar, Gujarat, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Genesis Ibrc India Limited before audits and certifications: compliance score 46/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Genesis Ibrc India Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 70/100, margin trends, ownership structure and peer set for Genesis Ibrc India Limited - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Review suggested. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Genesis Ibrc India Limited pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Genesis Ibrc India Limited - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Genesis Ibrc India Limited an active company?
Genesis Ibrc India Limited has MCA status “Active” with a compliance score of 46/100 (Caution Indicated).
Is Genesis Ibrc India Limited financially healthy?
Genesis Ibrc India Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.
Should I do business with Genesis Ibrc India Limited?
Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Genesis Ibrc India Limited?
Promoters hold a minority stake - exact percentages are in the full report. 7 active director(s) are on record.
Does Genesis Ibrc India Limited have loans or charges against its assets?
No open charges - all 8 registered charge(s) stand satisfied, indicating past borrowings were repaid.
Is Genesis Ibrc India Limited up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 46/100 (Caution Indicated).
Is it risky to lend to Genesis Ibrc India Limited?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
